• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Improving intestinal absorption of water-insoluble compounds: a membrane metabolism strategy.

作者信息

Amidon G L, Leesman G D, Elliott R L

出版信息

J Pharm Sci. 1980 Dec;69(12):1363-8. doi: 10.1002/jps.2600691203.

DOI:10.1002/jps.2600691203
PMID:6780682
Abstract

A strategy for improving the intestinal absorption of water-insoluble drugs was developed and tested. The strategy is based on making a soluble derivative of an insoluble compound which, in turn, is a substrate for enzymes in the surface coat of the brush border region of the microvillous membrane. Consequently, just prior to reaching the membrane, the physical properties of the diffusing species are changed from polar to nonpolar. The experimental test used two drug-drug derivative pairs, estrone-lysine estrone ester and p-nitroaniline-lysine p-nitroanilide. Wall permeabilities were determined using an external perfusion technique in the rat intestine and a laminar flow convective diffusion model for transport in the lumen. Analysis of the permeability results indicates that the derivatives have higher wall permeabilities than the parent compounds and that the microvillous surface coat may be a significant contributor to the intestinal wall resistance. Comparison of the absorption rates for estrone and the lysine estrone ester indicates that the absorption rate of the derivatives could be up to five orders of magnitude greater than that for the parent compound.

摘要

相似文献

1
Improving intestinal absorption of water-insoluble compounds: a membrane metabolism strategy.
J Pharm Sci. 1980 Dec;69(12):1363-8. doi: 10.1002/jps.2600691203.
2
A convective mass transfer model for determining intestinal wall permeabilities: laminar flow in a circular tube.一种用于确定肠壁通透性的对流质量传递模型:圆管中的层流。
J Theor Biol. 1980 Dec 21;87(4):757-71. doi: 10.1016/0022-5193(80)90115-0.
3
Intestinal absorption of amino acid derivatives: structural requirements for membrane hydrolysis.氨基酸衍生物的肠道吸收:膜水解的结构要求。
J Pharm Sci. 1983 Aug;72(8):943-4. doi: 10.1002/jps.2600720826.
4
Intestinal absorption of amino acid derivatives: importance of the free alpha-amino group.氨基酸衍生物的肠道吸收:游离α-氨基的重要性。
J Pharm Sci. 1982 Oct;71(10):1138-41. doi: 10.1002/jps.2600711015.
5
Oral absorption of 21-corticosteroid esters: a function of aqueous stability and intestinal enzyme activity and distribution.
J Pharm Sci. 1986 Oct;75(10):934-9. doi: 10.1002/jps.2600751004.
6
Polyethylene glycol 900 permeability of rat intestinal and colonic segments in vivo and brush border membrane vesicles in vitro.大鼠体内小肠和结肠段以及体外刷状缘膜囊泡对聚乙二醇900的通透性
J Lab Clin Med. 1989 Apr;113(4):505-15.
7
Permeability dominates in vivo intestinal absorption of P-gp substrate with high solubility and high permeability.对于具有高溶解度和高渗透性的P-糖蛋白底物,渗透性在其体内肠道吸收过程中起主导作用。
Mol Pharm. 2005 Jul-Aug;2(4):329-40. doi: 10.1021/mp0499104.
8
Calculation of the aqueous diffusion layer resistance for absorption in a tube: application to intestinal membrane permeability determination.
Pharm Res. 1991 Mar;8(3):298-305. doi: 10.1023/a:1015829128646.
9
Why is it challenging to predict intestinal drug absorption and oral bioavailability in human using rat model.为何利用大鼠模型预测人体肠道药物吸收和口服生物利用度具有挑战性?
Pharm Res. 2006 Aug;23(8):1675-86. doi: 10.1007/s11095-006-9041-2.
10
We may not measure the correct intestinal wall permeability coefficient of drugs: alternative absorptive clearance concept.我们可能无法测量药物正确的肠壁渗透系数:替代性吸收清除概念。
J Pharmacokinet Biopharm. 1995 Jun;23(3):323-31. doi: 10.1007/BF02354288.

引用本文的文献

1
Advances in Nanotechnology for Enhancing the Solubility and Bioavailability of Poorly Soluble Drugs.纳米技术在提高难溶性药物溶解度和生物利用度方面的进展。
Drug Des Devel Ther. 2024 May 1;18:1469-1495. doi: 10.2147/DDDT.S447496. eCollection 2024.
2
Pharmaceutical Excipients and Drug Metabolism: A Mini-Review.药物辅料与药物代谢:小型综述
Int J Mol Sci. 2020 Nov 3;21(21):8224. doi: 10.3390/ijms21218224.
3
Prospects and Challenges of Phospholipid-Based Prodrugs.基于磷脂的前药的前景与挑战。
Pharmaceutics. 2018 Nov 1;10(4):210. doi: 10.3390/pharmaceutics10040210.
4
Modern prodrug design for targeted oral drug delivery.用于靶向口服给药的现代前药设计。
Molecules. 2014 Oct 14;19(10):16489-505. doi: 10.3390/molecules191016489.
5
Comparison of intestinal absorption and disposition of structurally similar bioactive flavones in Radix Scutellariae.比较黄芩中结构相似的生物活性黄酮类化合物的肠道吸收和处置。
AAPS J. 2012 Mar;14(1):23-34. doi: 10.1208/s12248-011-9310-9. Epub 2011 Dec 14.
6
Role of intestinal first-pass metabolism of baicalein in its absorption process.黄芩苷元肠道首过代谢在其吸收过程中的作用。
Pharm Res. 2005 Jul;22(7):1050-8. doi: 10.1007/s11095-005-5303-7. Epub 2005 Jul 22.
7
Absorption rate limit considerations for oral phosphate prodrugs.口服磷酸盐前药的吸收速率限制因素
Pharm Res. 2003 Jun;20(6):848-56. doi: 10.1023/a:1023827017224.
8
Targeted prodrug design to optimize drug delivery.靶向前药设计以优化药物递送。
AAPS PharmSci. 2000;2(1):E6. doi: 10.1208/ps020106.
9
Evaluation of a targeted prodrug strategy of enhance oral absorption of poorly water-soluble compounds.评估一种用于增强难溶性化合物口服吸收的靶向前药策略。
Pharm Res. 1998 Jul;15(7):1012-8. doi: 10.1023/a:1011969808907.